S

ST Pharm Co Ltd
KOSDAQ:237690

Watchlist Manager
ST Pharm Co Ltd
KOSDAQ:237690
Watchlist
Price: 94 900 KRW 0.74% Market Closed
Market Cap: 1.9T KRW
Have any thoughts about
ST Pharm Co Ltd?
Write Note

ST Pharm Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ST Pharm Co Ltd
Interest Income Expense Peer Comparison

Comparables:
207940
F
220100
L
141080
C
268600
E
456070

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
S
ST Pharm Co Ltd
KOSDAQ:237690
Interest Income Expense
â‚©1.1B
CAGR 3-Years
N/A
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Samsung Biologics Co Ltd
KRX:207940
Interest Income Expense
â‚©48.6B
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
F
FutureChem Co Ltd
KOSDAQ:220100
Interest Income Expense
â‚©860.4m
CAGR 3-Years
N/A
CAGR 5-Years
-15%
CAGR 10-Years
N/A
L
LegoChem Biosciences Inc
KOSDAQ:141080
Interest Income Expense
â‚©17.8B
CAGR 3-Years
-3%
CAGR 5-Years
60%
CAGR 10-Years
45%
C
Cellivery Therapeutics Inc
KOSDAQ:268600
Interest Income Expense
-â‚©4.7B
CAGR 3-Years
-53%
CAGR 5-Years
13%
CAGR 10-Years
N/A
E
ENCell Co Ltd
KOSDAQ:456070
Interest Income Expense
â‚©6.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is ST Pharm Co Ltd's Interest Income Expense?
Interest Income Expense
1.1B KRW

Based on the financial report for Jun 30, 2024, ST Pharm Co Ltd's Interest Income Expense amounts to 1.1B KRW.

What is ST Pharm Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-11%

Over the last year, the Interest Income Expense growth was 400 760%.

Back to Top